Cababat, Fernando .

HRN: 15-71-03  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
02/23/2026
03/02/2026
IV
1.5 Grams
Q8
Cellulitis
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: